Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GEIF Ventures is a United Kingdom-based venture capital firm and co-investment fund that specializes in early-stage "Deep Tech" and life science companies. Established in 2002 as a partnership between the Great Eastern Investment Forum (GEIF) and the UK Small Business Service, the fund was designed to bridge the equity gap for startups by matching investments from business angels. Managed by the team that founded IQ Capital, GEIF Ventures has a strong focus on the Cambridge technology cluster, investing in sectors such as biotechnology, healthcare, synthetic biology, and advanced software. Its portfolio has included notable life science companies such as Novacta Biosystems, Sirigen, and Desktop Genetics. Today, the firm's legacy and operations are largely integrated into IQ Capital, which continues to support breakthrough scientific and technological innovations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GEIF Ventures.